Biotech (new drugs) stocks

바이오 신약

What are Biotech (new drugs) stocks in Korea?

The Biotech (new drugs) theme on jonbur groups 204 Korean stocks listed on KOSPI and KOSDAQ, worth ₩211T in total. On Oct 29, 2026 the group moved down 0.71% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.

Stocks: 204
Total market value: ₩211T
Day's move: −0.71%
As of: Oct 29, 2026
Largest members: Samsung Biologics, Celltrion, Alteogen

Earnings tracker · 2Q 2026

Past quarter

180 of 205 reportedOperating profit up vs a year ago: 89 of 170

Revenue+13.1%

Operating profit+39.3%

Net profit+247.1%

Combined, for the companies that have reported, vs the same quarter a year ago

Company	Reported	Revenue	vs a year ago	Operating profit	vs a year ago	vs last quarter	Op. margin
Samsung Biologics	Aug 14	₩1.3T	+2.4%	₩586B	+23.3%	+1.0%	44.4%36.9%
Celltrion	Aug 14	₩1.4T	+45.0%	₩452B	+86.3%	+40.4%	32.4%25.2%
Alteogen	Aug 7	₩69B	+269.5%	₩34B	Turned to profit	−13.0%	49.6%−2.3%
SK biopharmaceuticals	Aug 14	₩247B	+40.3%	₩97B	+56.9%	+8.1%	39.2%35.1%
Yuhan	Aug 14	₩639B	+10.4%	₩67B	+34.1%	+658.6%	10.5%8.6%
HLB	Aug 14	₩28B	+78.0%	−₩23B	Smaller loss	Smaller loss	−80.4%−146.6%
Hanmi Pharm	Aug 14	₩467B	+29.3%	₩131B	+116.9%	+144.4%	28.1%16.7%
SK Bioscience	Aug 13	₩156B	−3.8%	−₩16B	Smaller loss	Smaller loss	−10.1%−23.1%
LigaChem Biosciences	Aug 14	₩5.5B	−83.0%	−₩72B	Bigger loss	Bigger loss	−1,300.9%−66.1%
PharmaResearch	Aug 14	₩179B	+27.1%	₩66B	+19.0%	+16.0%	37.2%39.7%
ABL Bio	Aug 11	₩20B	−74.0%	−₩17B	Turned to loss	Smaller loss	−85.3%53.8%
Hugel	Aug 14	₩138B	+25.1%	₩56B	−1.1%	+17.6%	40.6%51.4%
Peptron	Aug 14	₩1.4B	+1.4%	−₩7.9B	Bigger loss	Bigger loss	−549.9%−349.2%
OliX Pharmaceuticals	Aug 14	₩2.6B	−58.0%	−₩14B	Bigger loss	Bigger loss	−533.3%−79.4%
Voronoi	—	₩0	−100.0%	−₩29B	Bigger loss	Bigger loss	—
Hanall Biopharma	Aug 14	₩44B	+8.8%	₩5.6B	+388.5%	+567.4%	12.6%2.8%
D&D Pharmatech	Aug 14	₩662M	−28.4%	−₩9.9B	Bigger loss	Smaller loss	−1,492.3%−871.7%
Caregen	Aug 14	₩19B	+3.7%	₩5.2B	−29.6%	−48.7%	27.9%41.1%
Mezzion Pharma	Aug 14	₩2.2B	+26.2%	−₩4.5B	Bigger loss	Smaller loss	−206.3%−203.4%
Seegene	Aug 14	₩136B	+19.2%	₩22B	+586.4%	−8.3%	15.9%2.8%
ST Pharm	Aug 14	₩108B	+58.9%	₩18B	+41.7%	+58.8%	16.9%18.9%
GC Biopharma	Aug 14	₩421B	−15.8%	₩1.7B	−93.7%	−85.3%	0.4%5.5%
Naturecell	Aug 14	₩6.2B	−3.3%	−₩702M	Bigger loss	Smaller loss	−11.3%−4.5%
OSCOTECInc	Aug 14	₩53B	+425.6%	₩39B	Turned to profit	Turned to profit	73.5%−6.3%
Aimed Bio	Aug 12	₩20B	—	₩8.5B	—	Turned to profit	42.2%
Kolon TissueGene	Aug 14	₩552,123	−41.3%	−₩4.8M	Bigger loss	Bigger loss	−869.2%−411.8%
Daewoong Pharma	Aug 14	₩448B	+10.6%	₩68B	+17.7%	+206.5%	15.2%14.3%
Curiox Biosystems	Aug 14	₩1.2B	+18.1%	−₩4.5B	Bigger loss	Bigger loss	−379.1%−397.5%
Daewoong	Aug 14	₩571B	+8.0%	₩77B	−10.2%	+60.4%	13.4%16.1%
Chong Kun Dang Pharmaceutical	Aug 14	₩478B	+10.0%	₩19B	−21.3%	+32.1%	3.9%5.4%
Qurient	Aug 14	₩1.9B	+3.4%	−₩13B	Bigger loss	Bigger loss	−672.7%−366.4%
Rznomics	Aug 13	₩808M	−88.6%	−₩6.9B	Turned to loss	Smaller loss	−848.2%43.1%
Chabiotech	Aug 13	₩316B	+5.9%	−₩28B	Bigger loss	Smaller loss	−8.9%−6.9%
G2GBIO	Aug 14	₩1.6B	+944.7%	−₩2.7B	Smaller loss	Smaller loss	−168.6%−1,789.3%
Proteina	Aug 14	₩349M	—	−₩4B	—	Smaller loss	−1,132.6%
Pharmicell	Aug 12	₩39B	+45.7%	₩13B	+62.0%	+1.1%	33.9%30.5%
Dong-A Pharmaceutical	Aug 14	₩412B	+18.9%	₩39B	+38.3%	+103.6%	9.4%8.1%
Onconic Therapeutics	Aug 12	₩24B	+158.7%	₩2.8B	+150.6%	−39.2%	11.4%11.8%
JW Pharmaceutical	Aug 14	₩222B	+16.2%	₩33B	+33.5%	−0.7%	15.0%13.1%
Hyundai Bioscience	—	₩520M	+56.3%	−₩5.5B	Bigger loss	Bigger loss	−1,063.7%−1,447.4%
HLB innoVation	Aug 13	₩11B	+17.8%	−₩9.2B	Smaller loss	Smaller loss	−87.2%−105.9%
Medy-Tox	Aug 13	₩69B	+11.4%	₩4.8B	−24.6%	−35.4%	6.9%10.2%
GI Innovation	Aug 14	₩0	−100.0%	−₩14B	Bigger loss	Bigger loss	—
Shinpoong Pharmaceutical	Aug 14	₩64B	+9.0%	−₩8B	Turned to loss	Bigger loss	−12.6%8.4%
GC	Aug 14	₩596B	−0.7%	₩6.6B	−69.4%	+116.3%	1.1%3.6%
GemVax & KAEL	Aug 14	₩23B	−9.2%	₩997M	Turned to profit	Turned to profit	4.4%−6.0%
HLB Life Science	Aug 13	₩15B	Turned to profit	−₩7.6B	Bigger loss	Bigger loss	−51.6%
IL Dong Pharmaceutical	Jul 30	₩148B	+6.8%	₩2B	+232.1%	−78.5%	1.3%0.4%
Penetrium Bioscience	Aug 14	₩2.1B	−16.2%	−₩1.9B	Bigger loss	Bigger loss	−87.9%−65.4%
AbClon	Aug 13	₩1.7B	+51.4%	−₩6.3B	Bigger loss	Bigger loss	−371.4%−299.7%
Bukwang Pharmaceutical IND	Aug 13	₩57B	+33.8%	₩1.4B	−29.9%	+27.7%	2.5%4.7%
Curocell	Aug 14	₩0	Flat	−₩9.7B	Smaller loss	Bigger loss	—
Orum Therapeutics	Aug 14	₩24M	+479.1%	−₩15B	Bigger loss	Smaller loss	−63,691.0%−240,123.7%
AprilBio	Aug 13	₩0	Flat	−₩2.9B	Bigger loss	Bigger loss	—
Dong-A ST	Aug 14	₩225B	+15.8%	₩6.3B	Turned to profit	−18.9%	2.8%−3.0%
Medipostco	Aug 14	₩19B	+5.3%	−₩24B	Bigger loss	Bigger loss	−129.6%−106.5%
Inventage Lab	Aug 26	₩176M	−79.7%	−₩10B	Bigger loss	Bigger loss	−5,851.5%−930.7%
Samyang Biopharm	Aug 14	₩36B	—	₩746M	—	−46.2%	2.1%
ToolGen	Aug 14	₩487M	+241.6%	−₩6.9B	Bigger loss	Bigger loss	−1,414.5%−4,439.8%
SillaJen	Aug 14	₩2.2B	−6.2%	−₩6.2B	Smaller loss	Bigger loss	−275.5%−258.7%
EuBiologics	Aug 13	₩33B	−8.3%	₩8.6B	−23.7%	+291.3%	25.8%31.0%
NKGen Biotech Korea	—	₩2.1B	+5.7%	₩186M	Turned to profit	Turned to profit	8.7%−34.6%
Genomictree	Aug 14	₩842M	−51.1%	−₩2.6B	Bigger loss	Smaller loss	−313.9%−87.5%
S.Biomedics	Aug 14	₩4.8B	+0.2%	−₩3.7B	Bigger loss	Bigger loss	−76.5%−42.6%
HLB Therapeutics	Aug 13	₩13B	−19.9%	−₩4.7B	Bigger loss	Bigger loss	−37.7%−4.2%
ImmuneOncia Therapeutics	Aug 14	₩0	—	−₩4.3B	—	Smaller loss	—
IntoCell	Aug 14	₩760M	+1,829.6%	−₩2.2B	Smaller loss	Smaller loss	−290.2%−9,447.2%
FutureChem	Aug 14	₩4.3B	+17.4%	−₩3.2B	Bigger loss	Bigger loss	−75.4%−52.6%
BioPlus	Aug 14	₩25B	+22.9%	₩6.2B	+202.3%	+10.5%	24.6%10.0%
IMBiologics	Aug 12	₩0	—	−₩2.7B	—	Turned to loss	—
Huons	Aug 14	₩147B	−5.8%	₩2.9B	−77.6%	Turned to profit	2.0%8.4%
GC Genome	Aug 14	₩8.3B	—	₩433M	—	+209.0%	5.2%
Binex	Aug 14	₩38B	−15.1%	−₩9.2B	Turned to loss	Bigger loss	−24.2%2.3%
3billion	Aug 13	₩3.8B	+46.4%	−₩1.7B	Bigger loss	Bigger loss	−43.9%−61.5%
Genome&Company	Aug 14	₩6.3B	+7.7%	−₩8B	Bigger loss	Bigger loss	−127.5%−127.6%
DuChemBio	Aug 14	₩11B	+17.8%	₩1.9B	+2.3%	+53.8%	17.2%19.9%
Bioneercorporation	Aug 14	₩96B	+8.9%	₩1.2B	−77.8%	Turned to profit	1.2%6.0%
Kangstem Biotech	Aug 13	₩642M	−37.7%	−₩6.1B	Bigger loss	Bigger loss	−944.3%−430.4%
curacle	Aug 14	₩7.2B	—	₩2.4B	Turned to profit	Turned to profit	32.8%
Kolon Life Science	Aug 14	₩51B	−4.5%	−₩785M	Turned to loss	Turned to loss	−1.6%2.4%
JW Lifescience	Aug 14	₩63B	+1.6%	₩9.3B	−0.4%	+0.2%	14.8%15.1%
Eone Diagnomics Genome Center	Aug 14	₩1.2B	Turned to profit	−₩716M	Turned to loss	Smaller loss	−58.5%
Helixmith	Aug 14	₩810M	+32.2%	−₩2.2B	Bigger loss	Smaller loss	−269.7%−324.8%
Cellbion	Aug 13	₩472M	+16.7%	−₩2.6B	Bigger loss	Bigger loss	−559.9%−515.3%
GC Cell	Aug 14	₩42B	−3.1%	−₩1B	Smaller loss	Smaller loss	−2.4%−7.9%
Aptabio Therapeutics	Aug 14	₩1.6B	+42.8%	−₩3.6B	Smaller loss	Smaller loss	−223.0%−368.5%
Aribio Holdings	—	₩11B	+9.1%	−₩2.8B	Smaller loss	Smaller loss	−25.9%−28.6%
Y-Biologics	Aug 14	₩1.5B	+32.8%	−₩3.8B	Bigger loss	Smaller loss	−244.9%−128.4%
ISU Abxis	Aug 14	₩15B	−34.6%	₩479M	−94.9%	Turned to profit	3.2%41.1%
Bio Solution	Aug 14	₩4.7B	+50.1%	−₩482M	Smaller loss	Smaller loss	−10.3%−44.0%
Anterogen	Aug 14	₩2.2B	+16.5%	−₩478M	Bigger loss	Smaller loss	−21.7%−24.1%
Cell Biotech	Aug 14	₩16B	+32.8%	₩1.6B	+28.0%	−48.5%	10.4%10.8%
JW Shinyak	Aug 14	₩22B	+9.4%	₩3.6B	+34.1%	+24.3%	16.6%13.6%
Kanaph Therapeutics	Aug 12	₩75M	—	−₩4.7B	—	Smaller loss	−6,265.3%
Hyundai Bioland	Aug 14	₩40B	+16.4%	₩7B	+27.9%	+35.7%	17.5%15.9%
Macrogen	Aug 14	₩51B	+4.1%	₩698M	Turned to profit	Turned to profit	1.4%−3.1%
Kukjeon	—	₩40B	+21.4%	₩1.5B	Turned to profit	−43.8%	3.7%−2.4%
TiumBio	Aug 14	₩4.5B	+71.3%	−₩4.2B	Bigger loss	Smaller loss	−94.8%−133.7%
Keeps Biopharma	Aug 14	₩75B	+72.8%	−₩2.4B	Bigger loss	Bigger loss	−3.2%−2.3%
Celemics	Aug 14	₩1.4B	+22.4%	−₩924M	Smaller loss	Smaller loss	−67.2%−119.5%
MedPacto	Aug 13	₩1B	+25.0%	−₩3.6B	Bigger loss	Smaller loss	−346.2%−304.8%
ViGenCell	Aug 14	₩571M	+91,691.0%	−₩2.5B	Smaller loss	Smaller loss	−444.0%−908,939.9%
Asta	Aug 14	₩1.2B	+230.3%	−₩839M	Turned to loss	Smaller loss	−71.7%10.2%
Genexine	Aug 13	₩972M	+44.7%	−₩10B	Bigger loss	Bigger loss	−1,079.6%−1,116.1%
Metabiomed	Aug 14	₩27B	+6.0%	₩6.3B	−19.6%	+29.2%	23.2%30.6%
DreamCIS	Aug 13	₩20B	+20.5%	₩2.3B	+50.0%	+320.8%	11.3%9.1%
Aribiolab	Aug 14	₩0	—	−₩2.5B	Smaller loss	Bigger loss	—
HLB bioStep	Aug 14	₩16B	−10.2%	−₩1.9B	Smaller loss	Smaller loss	−11.9%−24.2%
T&R Biofab	Aug 31	₩9.5B	+45.9%	−₩928M	Smaller loss	Smaller loss	−9.7%−29.3%
Aminologics	Aug 14	₩8.2B	+73.1%	₩2B	+818.6%	+215.0%	24.1%4.5%
iNtRON Biotechnology	Aug 14	₩2B	+66.0%	−₩1.6B	Smaller loss	Smaller loss	−80.4%−159.4%
Vaxcell-Bio Therapeutics	—	₩1.6B	−18.2%	−₩5B	Bigger loss	Bigger loss	−309.3%−206.7%
Corestemchemon	Aug 14	₩5.4B	−1.7%	−₩4.3B	Smaller loss	Smaller loss	−79.3%−123.6%
Cellumed	—	₩31B	−12.9%	₩1.6B	Turned to profit	Turned to profit	5.1%−12.2%
Enzychem Lifesciences	Aug 14	₩24B	+43.5%	−₩4.1B	Bigger loss	Bigger loss	−17.3%−22.4%
Choong ANG Vaccine Laboratory	Aug 5	₩12B	−1.2%	₩1.1B	−23.8%	−61.8%	9.6%12.5%
Bio-Fd&C	Aug 14	₩5.4B	+14.5%	₩2.1B	+14.1%	+105.0%	39.2%39.4%
SCL Science	Aug 14	₩7.6B	+68.9%	₩406M	Turned to profit	Turned to profit	5.3%−30.5%
Eye Gene	—	₩1.3B	+52.7%	−₩3.9B	Bigger loss	Bigger loss	−294.8%−279.6%
Pharos iBio	Aug 13	—	—	−₩2.3B	Smaller loss	Smaller loss	—
Polaris AI Pharma	Aug 14	₩15B	+6.5%	₩779M	−38.9%	+28.4%	5.3%9.2%
HLB Genex	Aug 13	₩11B	+13.2%	₩983M	−31.3%	−2.2%	8.7%14.3%
Choolip & Sciences	Aug 14	₩2.4B	+291.5%	−₩3.1B	Bigger loss	Bigger loss	−128.9%−253.6%
Sugentech	Aug 14	₩3.1B	−2.8%	−₩4.2B	Smaller loss	Smaller loss	−137.0%−154.1%
SunBio	Aug 13	₩2.2B	+29.9%	₩284M	+140.1%	−37.9%	12.7%6.9%
Inventera	Aug 14	₩0	—	−₩2.5B	—	Bigger loss	—
Naturalendo Tech	—	₩6.2B	+21.8%	−₩194M	Smaller loss	Bigger loss	−3.2%−20.8%
Amicogen	—	₩13B	+32.0%	−₩1.3B	Smaller loss	Smaller loss	−9.7%−41.8%
Optipharm	Aug 14	₩6.6B	+13.8%	−₩206M	Smaller loss	Smaller loss	−3.1%−7.5%
CTC Bio	Aug 12	₩34B	−4.9%	₩3.8B	+67.3%	−17.5%	11.3%6.4%
Pangen Biotech	Aug 13	₩4B	+13.5%	−₩220M	Turned to loss	Turned to loss	−5.6%23.9%
PharmGen Science	—	₩48B	+4.0%	₩1.8B	−45.8%	+1.7%	3.8%7.2%
Abion	Aug 14	₩137M	−35.5%	−₩4.3B	Smaller loss	Smaller loss	−3,155.4%−2,055.7%
Adbiotech	Aug 14	₩2.9B	+2.0%	−₩1.9B	Bigger loss	Bigger loss	−66.6%−66.3%
Tego Science	Aug 14	₩2B	+21.9%	−₩1.2B	Bigger loss	Smaller loss	−58.5%−28.6%
HLB Panagene	Aug 14	₩3.7B	+1.9%	−₩158M	Smaller loss	Smaller loss	−4.3%−5.5%
NeoImmuneTech	—	₩788,200	+4,383.8%	−₩2.8M	Smaller loss	Smaller loss	−359.8%−27,107.9%
Cellid	Aug 14	₩2.1B	−3.0%	−₩2.5B	Bigger loss	Bigger loss	−121.2%−113.2%
Cytogen	Aug 13	₩6.8B	+8.7%	−₩1.2B	Smaller loss	Smaller loss	−17.8%−30.7%
ENCell	Aug 14	₩868M	−26.3%	−₩4.7B	Bigger loss	Smaller loss	−539.0%−379.9%
Psomagen	Aug 14	₩8.1M	−21.4%	₩121,820	−70.0%	Turned to profit	1.5%3.9%
KoBioLabs	Aug 13	₩22B	+23.8%	−₩2B	Smaller loss	Smaller loss	−9.2%−15.9%
BL Pharmtech	Aug 14	−₩143M	Turned to loss	−₩1.3B	Bigger loss	Turned to loss	—
Geninus	Aug 14	₩3.6B	+40.3%	−₩4.6B	Bigger loss	Bigger loss	−127.4%−155.8%
Aprogen	Aug 14	₩36B	+47.0%	−₩22B	Smaller loss	Bigger loss	−63.2%−98.9%
GeneOne Life Science	Aug 14	₩2.1B	−69.8%	−₩13B	Bigger loss	Bigger loss	−623.0%−149.5%
CJ Bioscience	Aug 14	₩898M	+14.6%	−₩6.4B	Smaller loss	Bigger loss	−712.5%−887.2%
QuadMedicine	Aug 13	₩1.5B	−63.4%	−₩2.4B	Turned to loss	Smaller loss	−155.4%0.8%
Protia	Aug 12	₩5.3B	+39.1%	₩1.6B	+56.8%	+115.4%	30.6%27.1%
Gencurix	Aug 13	₩3B	+49.3%	−₩702M	Smaller loss	Smaller loss	−23.5%−65.5%
RPbio	Aug 14	₩40B	+11.4%	₩4.1B	+76.0%	+68.8%	10.3%6.5%
Quratis	Aug 14	₩320M	−33.3%	−₩3B	Smaller loss	Bigger loss	−939.2%−688.8%
Gene Bio Tech	Aug 14	₩23B	−0.5%	₩1.5B	+67.0%	+96.3%	6.5%3.9%
Aprogen Biologics	Aug 13	₩23B	+54.9%	−₩17B	Smaller loss	Bigger loss	−75.7%−120.5%
Wonbiogen	—	₩9.9B	+18.3%	₩2.8B	+46.9%	+31.3%	28.0%22.5%
Oncocross	Aug 14	₩58M	−57.8%	−₩2.7B	Bigger loss	Bigger loss	−4,642.0%−1,356.4%
HLB Pep	Aug 13	₩1.3B	+2.2%	−₩1.4B	Bigger loss	Smaller loss	−109.8%−102.5%
Organoidsciences	Aug 14	₩598M	—	−₩4.4B	—	Bigger loss	−728.2%
Kainos Medicine	Aug 14	₩408M	+131.2%	−₩1.1B	Bigger loss	Bigger loss	−258.1%−535.4%
Kolmar BioTech	Aug 14	₩11B	+55.0%	−₩19M	Smaller loss	Turned to loss	−0.2%−22.7%
Eutilex	Aug 14	₩535M	−77.0%	−₩2.2B	Smaller loss	Smaller loss	−402.5%−224.4%
IMBdx	Aug 14	₩1.5B	0.0%	−₩1.4B	Smaller loss	Smaller loss	−93.2%−126.7%
Genolution	—	₩3.1B	+7.3%	−₩1.6B	Smaller loss	Bigger loss	−51.6%−58.8%
Biotoxtech	Aug 14	₩14B	+50.3%	−₩182M	Smaller loss	Smaller loss	−1.3%−20.0%
SLSBio(Specialty Lab Solution Bio)	Aug 14	₩1.3B	−18.7%	−₩898M	Bigger loss	Smaller loss	−69.4%−42.4%
Genematrix	—	₩2.9B	+8.1%	₩393M	Turned to profit	Turned to profit	13.5%−3.4%
Synteka Bio	Aug 14	₩449M	+29.9%	−₩2.2B	Smaller loss	Smaller loss	−494.9%−868.0%
C&R Research	Aug 14	₩18B	+5.0%	₩176M	−86.0%	Turned to profit	1.0%7.4%
GFC Life Science	—	₩5.5B	—	₩581M	—	+25.2%	10.6%
Shaperon	Aug 12	₩41M	Turned to profit	−₩3.1B	Smaller loss	Smaller loss	−7,565.0%
Enbioco	Aug 13	₩10B	+22.5%	₩172M	Turned to profit	−94.5%	1.6%−2.0%
WooGene B&Gco	Aug 14	₩15B	+12.7%	₩1.4B	+569.6%	+95.6%	8.9%1.5%
Xcell Therapeutics	Aug 14	₩1.9B	+775.4%	−₩2.8B	Bigger loss	Smaller loss	−142.2%−1,203.2%
PeopleBio	Aug 14	₩1.7B	+127.9%	−₩749M	Smaller loss	Smaller loss	−44.9%−269.6%
Celestra	Aug 14	₩0	−100.0%	−₩447M	Smaller loss	Bigger loss	—
Olipass	—	₩1.2B	+634.3%	−₩117M	Smaller loss	Smaller loss	−10.0%−1,450.7%
From Bio	Aug 14	₩15B	−7.5%	−₩553M	Smaller loss	Smaller loss	−3.8%−24.3%
NGeneBio	Aug 14	₩12B	+590.3%	−₩1.2B	Smaller loss	Smaller loss	−9.5%−103.5%
Phionx	—	₩1.8M	+34.4%	−₩833,093	Smaller loss	Bigger loss	−45.2%−101.3%
BioInfra	Aug 12	₩8.5B	+39.7%	₩76M	Turned to profit	Turned to profit	0.9%−18.4%
Orientbio	Not yet
Hans Biomed	Not yet
208340	Not yet
Prestige BioPharma	Not yet
Ingenia Therapeutics	Not yet
Ensol Biosciences	Not yet
Imgt	Not yet
HL Genomics	Not yet
Epi Biotech	Not yet
NovMetaPharma	Not yet
ProGen	Not yet
Plumbline Life Sciences	Not yet
Moogene Medi	Not yet
Curachem	Not yet
Invites Biocore	Not yet
AngioLab	Not yet
Median Diagnostics	Not yet
Cronex	Not yet
Medizen Humancare	Not yet
OceansBio	Not yet
BioInfra Life Science	Not yet
341170	Not yet
072520	Not yet
283100	Not yet
258540	Not yet

Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.

Technical breadth

After the close on Oct 29, 2026

Above 20-day average: 11.6%
Above 60-day average: 19.7%
RSI above 70: 0.6%
RSI below 30: 6.4%
52-week highs: 0
52-week lows: 10

Index gauge · Short term

Bearish

0 bullish, 2 neutral, 7 bearish

Index gauge · Medium term

Bearish

0 bullish, 1 neutral, 7 bearish

Technical read

The Biotech (new drugs) theme covers 173 members, and only about 11.6% of them trade above their 20-day averages while about 19.7% sit above their 60-day averages. Momentum is weak across the group, with 6.4% of members showing oversold RSI readings and only 0.6% showing overbought readings, and 10 members touched 52-week lows against none at 52-week highs. The equal-weighted member index is bearish on both short and medium horizons, with an RSI of 36.8 and price below its cloud.

Written by AI from the indicator values above. Not advice.

Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.

Credit & macro

MaturitiesOct 29, 202675Hyundai Department Store: ₩200bn of bonds due in the next 6 months vs ₩158bn cash₩200bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.Hyundai Department Store Daewonkangup Hyundai G.F. Holdings Zinus Handsome Samwonsteel
MaturitiesOct 23, 202685ISU Abxis: ₩50bn of bonds due in the next 6 months vs ₩23bn cash₩50bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.ISU Abxis
MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK Reit SK hynix SK Networks SK Discovery SKC SK Telecom

ETFs for this theme

All ETFs →

AUM · Flow 1w

Creators talking about this

Doctors begin to prescribe country’s first domestically developed obesity drug on Thurs.Arirang News · via YouTube

Biotech (new drugs)

−1.43%

바이오 신약

The Biotech (new drugs) theme in Korea covers companies that research, develop, and commercialize novel pharmaceutical drugs, including small-molecule compounds, biologics, and next-generation therapies such as antibody and cell treatments. Korean investors often group these firms together because they share a long development timeline, heavy R&D spending, and milestones tied to clinical trials, regulatory approvals, and licensing deals with global pharmaceutical companies. The theme is distinct from generic drug manufacturers and from contract manufacturing businesses, though some companies operate in several of these areas.

204 companies · 42 up · 22 flat · 140 down

Traded value: ₩644B
Value vs 20-day average: 0.72×
Top gainer: Phionx
Largest company: Samsung Biologics

Companies in this theme

Market cap Value traded Gainers Losers NPS stake

All KOSPI KOSDAQ

NPS owns > 5%

Company	Price	Daily	Traded value	Market cap	NPS
Samsung Biologics207940 · KOSPI	₩1,366,000	−0.44%	₩58B	₩63T	6.88%
Celltrion068270 · KOSPI	₩189,300	−0.26%	₩71B	₩44T	7.28%
Alteogen196170 · KOSDAQ	₩220,000	−1.35%	₩52B	₩15T	2.68%
SK biopharmaceuticals326030 · KOSPI	₩77,800	+3.46%	₩16B	₩6.1T	6.00%
Yuhan000100 · KOSPI	₩74,700	−3.36%	₩24B	₩5.5T	6.83%
HLB028300 · KOSDAQ	₩39,700	−2.34%	₩20B	₩5.3T	1.16%
Hanmi Pharm128940 · KOSPI	₩388,500	+5.14%	₩63B	₩5T	9.61%
SK Bioscience302440 · KOSPI	₩32,200	+0.16%	₩2.2B	₩2.5T	5.50%
LigaChem Biosciences141080 · KOSDAQ	₩64,000	−3.32%	₩15B	₩2.4T	4.99%
PharmaResearch214450 · KOSDAQ	₩222,500	−2.63%	₩21B	₩2.3T	7.14%
ABL Bio298380 · KOSDAQ	₩41,000	−1.91%	₩10B	₩2.3T	4.02%
Hugel145020 · KOSDAQ	₩183,300	+0.99%	₩7.7B	₩2.3T	2.29%
Peptron087010 · KOSDAQ	₩97,200	0.00%	₩12B	₩2.3T	1.63%
OliX Pharmaceuticals226950 · KOSDAQ	₩96,500	−0.82%	₩15B	₩2.2T	5.04%
Voronoi310210 · KOSDAQ	₩115,200	−4.87%	₩8.3B	₩2.1T	2.78%
Hanall Biopharma009420 · KOSPI	₩37,800	−1.82%	₩7.9B	₩2T	10.56%
D&D Pharmatech347850 · KOSDAQ	₩41,700	−2.80%	₩16B	₩1.9T	1.75%
Caregen214370 · KOSDAQ	₩33,950	−1.16%	₩1.5B	₩1.8T	0.65%
Mezzion Pharma140410 · KOSDAQ	₩52,600	0.00%	₩4.3B	₩1.6T	0.50%
Seegene096530 · KOSDAQ	₩33,600	+0.30%	₩10B	₩1.6T	0.64%
ST Pharm237690 · KOSDAQ	₩74,000	−4.15%	₩9.1B	₩1.5T	5.77%
GC Biopharma006280 · KOSPI	₩132,000	+1.15%	₩1.9B	₩1.5T	6.68%
Naturecell007390 · KOSDAQ	₩22,200	+0.23%	₩3.7B	₩1.4T	0.44%
OSCOTECInc039200 · KOSDAQ	₩36,500	−0.41%	₩3.6B	₩1.4T	3.87%
Aimed Bio0009K0 · KOSDAQ	₩19,850	−4.80%	₩5B	₩1.3T	0.03%
Kolon TissueGene950160 · KOSDAQ	₩14,300	−2.05%	₩4B	₩1.2T	0.57%
Daewoong Pharma069620 · KOSPI	₩101,500	+1.60%	₩1.7B	₩1.2T	10.30%
Ingenia Therapeutics950260 · KOSDAQ	₩23,500	−0.42%	₩8.1B	₩1.2T	—
Curiox Biosystems445680 · KOSDAQ	₩60,600	−2.88%	₩7.2B	₩1T	1.25%
Daewoong003090 · KOSPI	₩14,900	+0.68%	₩952M	₩866B	3.25%
Chong Kun Dang Pharmaceutical185750 · KOSPI	₩62,500	+0.97%	₩703M	₩863B	6.34%
Qurient115180 · KOSDAQ	₩17,830	−0.78%	₩1.7B	₩669B	3.88%
Rznomics476830 · KOSDAQ	₩22,650	−3.21%	₩6.8B	₩635B	3.96%
Chabiotech085660 · KOSDAQ	₩6,760	−4.52%	₩2.3B	₩628B	0.31%
G2GBIO456160 · KOSDAQ	₩36,600	−3.43%	₩16B	₩609B	2.41%
Proteina468530 · KOSDAQ	₩53,900	+4.66%	₩13B	₩599B	3.78%
Pharmicell005690 · KOSPI	₩9,800	−4.20%	₩4.6B	₩588B	2.38%
Dong-A Pharmaceutical000640 · KOSPI	₩86,300	−1.48%	₩763M	₩581B	9.45%
Onconic Therapeutics476060 · KOSDAQ	₩12,620	−3.44%	₩2.1B	₩573B	—
JW Pharmaceutical001060 · KOSPI	₩23,150	−0.22%	₩738M	₩569B	2.44%
Hyundai Bioscience048410 · KOSDAQ	₩5,670	−3.41%	₩4.7B	₩547B	0.37%
HLB innoVation024850 · KOSDAQ	₩14,160	−4.97%	₩1.3B	₩489B	—
Medy-Tox086900 · KOSDAQ	₩64,200	−2.43%	₩820M	₩469B	1.44%
GI Innovation358570 · KOSDAQ	₩6,940	−2.80%	₩1.8B	₩448B	4.07%
Shinpoong Pharmaceutical019170 · KOSPI	₩8,410	−0.59%	₩1.5B	₩441B	0.39%
GC005250 · KOSPI	₩9,120	−0.11%	₩515M	₩429B	5.94%
GemVax & KAEL082270 · KOSDAQ	₩9,050	+0.11%	₩1.8B	₩412B	2.55%
HLB Life Science067630 · KOSDAQ	₩3,280	−1.80%	₩523M	₩400B	0.07%
IL Dong Pharmaceutical249420 · KOSPI	₩12,570	−1.72%	₩7.8B	₩398B	2.30%
Penetrium Bioscience187660 · KOSDAQ	₩6,170	−7.36%	₩3.7B	₩395B	—
AbClon174900 · KOSDAQ	₩19,610	−7.06%	₩6B	₩391B	3.57%
Bukwang Pharmaceutical IND003000 · KOSPI	₩3,700	−1.33%	₩848M	₩365B	0.68%
Curocell372320 · KOSDAQ	₩23,700	−5.20%	₩764M	₩361B	0.46%
Orum Therapeutics475830 · KOSDAQ	₩15,810	−3.36%	₩2.9B	₩344B	0.09%
AprilBio397030 · KOSDAQ	₩12,400	0.00%	₩2.8B	₩342B	0.95%
Dong-A ST170900 · KOSPI	₩34,000	−2.58%	₩399M	₩331B	4.78%
Medipostco078160 · KOSDAQ	₩8,350	−3.69%	₩408M	₩327B	1.55%
Inventage Lab389470 · KOSDAQ	₩23,000	−3.97%	₩1.5B	₩306B	0.31%
Samyang Biopharm0120G0 · KOSPI	₩40,900	−1.56%	₩1.2B	₩304B	1.73%
ToolGen199800 · KOSDAQ	₩30,950	+3.86%	₩565M	₩303B	0.43%
SillaJen215600 · KOSDAQ	₩2,060	−2.83%	₩1.3B	₩285B	0.09%
EuBiologics206650 · KOSDAQ	₩7,800	+2.36%	₩724M	₩284B	0.17%
NKGen Biotech Korea182400 · KOSDAQ	₩3,670	0.00%	₩0	₩265B	—
Hans Biomed042520 · KOSDAQ	₩17,530	−1.96%	₩1.4B	₩250B	4.88%
Prestige BioPharma950210 · KOSPI	₩4,155	−1.54%	₩441M	₩250B	0.15%
Genomictree228760 · KOSDAQ	₩9,900	−4.81%	₩613M	₩246B	0.51%
S.Biomedics304360 · KOSDAQ	₩19,600	−2.73%	₩281M	₩245B	—
HLB Therapeutics115450 · KOSDAQ	₩2,560	−2.85%	₩901M	₩242B	0.10%
ImmuneOncia Therapeutics424870 · KOSDAQ	₩2,600	−9.41%	₩1.2B	₩238B	—
IntoCell287840 · KOSDAQ	₩15,530	−4.72%	₩343M	₩233B	1.04%
FutureChem220100 · KOSDAQ	₩7,480	−7.43%	₩2.1B	₩232B	0.76%
BioPlus099430 · KOSDAQ	₩3,410	+1.49%	₩676M	₩210B	0.42%
IMBiologics493280 · KOSDAQ	₩13,800	−3.02%	₩1.3B	₩205B	—
Huons243070 · KOSDAQ	₩17,030	−1.73%	₩290M	₩204B	0.71%
GC Genome340450 · KOSDAQ	₩8,580	+1.66%	₩6.5B	₩203B	—
Binex053030 · KOSDAQ	₩6,080	−0.33%	₩321M	₩199B	2.17%
3billion394800 · KOSDAQ	₩6,150	−0.81%	₩4.6B	₩196B	4.02%
Genome&Company314130 · KOSDAQ	₩3,640	−5.21%	₩843M	₩190B	0.24%
DuChemBio176750 · KOSDAQ	₩6,400	−10.61%	₩3.5B	₩182B	0.04%
Bioneercorporation064550 · KOSDAQ	₩6,980	−1.27%	₩1B	₩180B	0.10%
Kangstem Biotech217730 · KOSDAQ	₩1,899	+1.93%	₩627M	₩179B	0.10%
curacle365270 · KOSDAQ	₩8,020	−2.31%	₩327M	₩178B	0.50%
Kolon Life Science102940 · KOSDAQ	₩12,830	−0.85%	₩834M	₩168B	0.50%
JW Lifescience234080 · KOSPI	₩10,590	+0.76%	₩91M	₩168B	0.72%
Eone Diagnomics Genome Center245620 · KOSDAQ	₩741	0.00%	₩0	₩167B	—
Helixmith084990 · KOSDAQ	₩3,620	−2.95%	₩712M	₩167B	0.12%
Cellbion308430 · KOSDAQ	₩12,720	+6.53%	₩319M	₩164B	—
GC Cell144510 · KOSDAQ	₩9,750	−6.88%	₩1.3B	₩154B	0.06%
Aptabio Therapeutics293780 · KOSDAQ	₩5,310	−3.28%	₩269M	₩149B	0.05%
Aribio Holdings290690 · KOSDAQ	₩2,685	−0.56%	₩842M	₩143B	—
Y-Biologics338840 · KOSDAQ	₩9,250	−1.49%	₩867M	₩142B	0.17%
ISU Abxis086890 · KOSDAQ	₩3,490	−2.92%	₩163M	₩142B	0.20%
Bio Solution086820 · KOSDAQ	₩5,460	−2.33%	₩313M	₩142B	0.15%
Anterogen065660 · KOSDAQ	₩14,080	+0.86%	₩370M	₩141B	0.30%
Cell Biotech049960 · KOSDAQ	₩14,800	−0.20%	₩33M	₩139B	0.00%
Ensol Biosciences140610 · KONEX	₩9,180	+2.91%	₩24M	₩132B	—
JW Shinyak067290 · KOSDAQ	₩2,300	−3.16%	₩19B	₩129B	—
Kanaph Therapeutics0082N0 · KOSDAQ	₩9,650	−3.79%	₩866M	₩128B	—
Hyundai Bioland052260 · KOSDAQ	₩4,105	−3.64%	₩513M	₩123B	0.00%
Macrogen038290 · KOSDAQ	₩10,950	−2.58%	₩279M	₩119B	4.56%
Kukjeon307750 · KOSDAQ	₩2,075	−2.12%	₩716M	₩112B	—
TiumBio321550 · KOSDAQ	₩3,715	−3.13%	₩348M	₩112B	0.31%
Keeps Biopharma256940 · KOSDAQ	₩5,310	−3.63%	₩259M	₩107B	—
Celemics331920 · KOSDAQ	₩9,220	−0.11%	₩140M	₩103B	—
MedPacto235980 · KOSDAQ	₩2,970	+1.54%	₩274M	₩102B	2.96%
ViGenCell308080 · KOSDAQ	₩4,870	−3.37%	₩501M	₩100B	0.59%
Asta246720 · KOSDAQ	₩6,070	0.00%	₩0	₩99B	—
Genexine095700 · KOSDAQ	₩2,165	−3.78%	₩188M	₩99B	0.15%
Metabiomed059210 · KOSDAQ	₩3,625	−0.28%	₩491M	₩98B	—
DreamCIS223250 · KOSDAQ	₩4,000	+3.36%	₩827M	₩98B	—
Aribiolab261780 · KOSDAQ	₩3,345	−1.76%	₩1.2B	₩97B	—
HLB bioStep278650 · KOSDAQ	₩5,250	−11.17%	₩3.1B	₩92B	—
T&R Biofab246710 · KOSDAQ	₩1,877	−1.52%	₩598M	₩89B	0.95%
Aminologics074430 · KOSDAQ	₩1,000	−0.70%	₩62M	₩89B	—
iNtRON Biotechnology048530 · KOSDAQ	₩2,875	−5.58%	₩378M	₩89B	1.38%
Vaxcell-Bio Therapeutics323990 · KOSDAQ	₩3,790	−4.17%	₩260M	₩88B	0.07%
Corestemchemon166480 · KOSDAQ	₩1,660	−2.64%	₩126M	₩88B	0.02%
Cellumed049180 · KOSDAQ	₩1,009	0.00%	₩0	₩84B	—
Enzychem Lifesciences183490 · KOSDAQ	₩990	0.00%	₩0	₩84B	0.30%
Choong ANG Vaccine Laboratory072020 · KOSDAQ	₩8,870	+0.45%	₩69M	₩82B	—
Bio-Fd&C251120 · KOSDAQ	₩9,200	−0.86%	₩112M	₩80B	0.59%
SCL Science246960 · KOSDAQ	₩2,210	+3.51%	₩328M	₩77B	—
Eye Gene185490 · KOSDAQ	₩1,750	+1.92%	₩81M	₩76B	2.40%
Pharos iBio388870 · KOSDAQ	₩5,780	−1.87%	₩169M	₩75B	—
Polaris AI Pharma041910 · KOSDAQ	₩5,580	−1.06%	₩115M	₩74B	—
HLB Genex187420 · KOSDAQ	₩2,255	−1.96%	₩278M	₩74B	—
Yuhan Pref.000105 · KOSPI	₩63,700	−2.30%	₩25M	₩73B	—
Choolip & Sciences291650 · KOSDAQ	₩2,300	−0.43%	₩85M	₩70B	—
Sugentech253840 · KOSDAQ	₩4,085	−0.49%	₩248M	₩68B	—
SunBio067370 · KOSDAQ	₩5,530	−2.64%	₩28M	₩68B	—
Inventera0007J0 · KOSDAQ	₩8,340	−5.55%	₩268M	₩66B	—
Naturalendo Tech168330 · KOSDAQ	₩2,065	−1.43%	₩6.9M	₩66B	0.10%
Amicogen092040 · KOSDAQ	₩906	−0.98%	₩266M	₩64B	0.37%
Optipharm153710 · KOSDAQ	₩4,345	−0.69%	₩21M	₩64B	0.44%
CTC Bio060590 · KOSDAQ	₩2,635	−1.86%	₩103M	₩64B	—
Pangen Biotech222110 · KOSDAQ	₩4,610	−0.65%	₩5.6M	₩62B	—
PharmGen Science004720 · KOSPI	₩2,750	+0.36%	₩45M	₩62B	0.08%
Abion203400 · KOSDAQ	₩3,380	0.00%	₩0	₩61B	0.98%
Adbiotech179530 · KOSDAQ	₩1,930	+1.10%	₩89M	₩60B	—
Tego Science191420 · KOSDAQ	₩7,260	−1.89%	₩20M	₩59B	—
HLB Panagene046210 · KOSDAQ	₩1,265	−2.69%	₩191M	₩58B	—
Imgt456570 · KONEX	₩10,670	+0.38%	₩2.6M	₩56B	—
NeoImmuneTech950220 · KOSDAQ	₩1,632	−2.68%	₩137M	₩56B	—
HL Genomics0156T0 · KOSDAQ	₩7,120	−0.42%	₩354M	₩55B	—
Cellid299660 · KOSDAQ	₩1,861	−8.77%	₩560M	₩55B	0.02%
Cytogen217330 · KOSDAQ	₩2,345	−5.25%	₩167M	₩54B	—
ENCell456070 · KOSDAQ	₩4,860	−3.38%	₩410M	₩54B	—
Psomagen950200 · KOSDAQ	₩2,755	−7.08%	₩224M	₩53B	—
KoBioLabs348150 · KOSDAQ	₩2,720	0.00%	₩33M	₩53B	—
BL Pharmtech065170 · KOSDAQ	₩1,791	+1.36%	₩855M	₩50B	—
Epi Biotech446440 · KONEX	₩21,500	+2.38%	₩1.1M	₩50B	—
Geninus389030 · KOSDAQ	₩1,250	−4.21%	₩610M	₩49B	—
Aprogen007460 · KOSPI	₩1,897	−2.22%	₩216M	₩49B	0.76%
GeneOne Life Science011000 · KOSPI	₩2,670	0.00%	₩0	₩49B	0.19%
CJ Bioscience311690 · KOSDAQ	₩3,690	+1.10%	₩21M	₩48B	—
QuadMedicine464490 · KOSDAQ	₩4,125	−5.50%	₩104M	₩47B	—
Protia303360 · KOSDAQ	₩3,615	−0.69%	₩83M	₩47B	—
Gencurix229000 · KOSDAQ	₩1,957	0.00%	₩0	₩46B	0.81%
RPbio314140 · KOSDAQ	₩5,250	−0.94%	₩33M	₩45B	—
Quratis348080 · KOSDAQ	₩3,515	+0.57%	₩64M	₩45B	—
NovMetaPharma229500 · KONEX	₩3,375	−2.32%	₩111M	₩44B	—
Gene Bio Tech086060 · KOSDAQ	₩5,060	−1.56%	₩63M	₩44B	—
Aprogen Biologics003060 · KOSPI	₩1,380	−1.00%	₩124M	₩42B	0.08%
Wonbiogen307280 · KOSDAQ	₩5,620	−2.43%	₩167M	₩40B	—
Oncocross382150 · KOSDAQ	₩3,030	−3.66%	₩71M	₩40B	—
HLB Pep196300 · KOSDAQ	₩4,065	−0.85%	₩22M	₩39B	—
Organoidsciences476040 · KOSDAQ	₩5,680	−3.73%	₩123M	₩37B	1.38%
Orientbio002630 · KOSPI	₩1,229	−4.58%	₩57M	₩36B	0.06%
Kainos Medicine284620 · KOSDAQ	₩1,087	0.00%	₩0	₩36B	—
Kolmar BioTech215380 · KOSDAQ	₩2,125	−0.70%	₩31M	₩36B	—
Eutilex263050 · KOSDAQ	₩959	0.00%	₩0	₩35B	0.74%
IMBdx461030 · KOSDAQ	₩2,395	−3.23%	₩61M	₩34B	0.31%
Genolution225220 · KOSDAQ	₩1,720	+0.17%	₩54M	₩33B	—
Biotoxtech086040 · KOSDAQ	₩2,030	−3.79%	₩29M	₩32B	—
ProGen296160 · KONEX	₩2,040	−2.86%	₩20M	₩31B	—
SLSBio(Specialty Lab Solution Bio)246250 · KOSDAQ	₩1,969	0.00%	₩0	₩30B	—
Genematrix109820 · KOSDAQ	₩1,419	−0.91%	₩63M	₩29B	—
Synteka Bio226330 · KOSDAQ	₩1,059	−1.40%	₩83M	₩26B	0.18%
C&R Research359090 · KOSDAQ	₩2,215	+0.45%	₩12M	₩25B	—
GFC Life Science388610 · KOSDAQ	₩4,445	−0.78%	₩39M	₩24B	—
Shaperon378800 · KOSDAQ	₩2,335	−0.64%	₩66M	₩22B	—
Enbioco352940 · KOSDAQ	₩1,884	−0.89%	₩6.4M	₩20B	—
WooGene B&Gco018620 · KOSDAQ	₩2,885	+4.15%	₩105M	₩20B	—
Plumbline Life Sciences222670 · KONEX	₩4,635	0.00%	₩0	₩19B	—
Moogene Medi322970 · KONEX	₩1,845	+1.93%	₩184,501	₩19B	—
Xcell Therapeutics373110 · KOSDAQ	₩998	−4.04%	₩81M	₩17B	—
GC 2nd Pref.005257 · KOSPI	₩16,980	+3.22%	₩1.1M	₩14B	—
PeopleBio304840 · KOSDAQ	₩561	0.00%	₩0	₩14B	—
Celestra352770 · KOSDAQ	₩5,250	0.00%	₩0	₩14B	—
Olipass244460 · KOSDAQ	₩1,651	0.00%	₩0	₩13B	—
Curachem456190 · KONEX	₩7,210	0.00%	₩0	₩13B	—
Invites Biocore216400 · KONEX	₩1,400	+2.94%	₩1,400	₩11B	—
From Bio377220 · KOSDAQ	₩1,882	−1.41%	₩169M	₩11B	—
JW Pharmaceutical 2nd Pref.001067 · KOSPI	₩49,700	+0.20%	₩2.6M	₩10B	—
NGeneBio354200 · KOSDAQ	₩642	−3.46%	₩180M	₩10B	—
AngioLab251280 · KONEX	₩2,345	+8.06%	₩2.2M	₩8.6B	—
Median Diagnostics233250 · KONEX	₩4,800	0.00%	₩0	₩8.4B	—
Phionx900100 · KOSDAQ	₩1,501	+29.96%	₩343M	₩7.9B	—
JW Pharmaceutical Pref.001065 · KOSPI	₩21,100	−0.47%	₩2.1M	₩7.2B	—
BioInfra199730 · KOSDAQ	₩1,362	−16.95%	₩475M	₩6.6B	—
Cronex215570 · KONEX	₩598	−0.33%	₩0	₩4B	—
Medizen Humancare236340 · KONEX	₩1,240	−8.15%	₩222,420	₩3.8B	—
OceansBio332190 · KONEX	₩2,100	−4.33%	₩0	₩3.1B	—
BioInfra Life Science266470 · KONEX	₩99	0.00%	₩193,113	₩2.8B	—

Source: KRX statistical information